Citizens Holding Company logo

Citizens Holding Company (CIZN)

Market Closed
3 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
8. 48
+0.03
+0.36%
$
53.55M Market Cap
- P/E Ratio
0.64% Div Yield
500 Volume
- Eps
$ 8.45
Previous Close
Day Range
8.46 8.48
Year Range
7 11
Want to track CIZN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 12 days
Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease and cancer, today announced that it will participate in a fireside chat at the Citizens Life Sciences Conference being held in New York, May 7-8, 2025.

Globenewswire | 2 months ago
Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference

Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the Citizens Life Sciences Conference, being held May 7-8, 2025, in New York, NY.

Globenewswire | 2 months ago
Ping An Rapidly Launches Overseas Emergency Assistance to Support Chinese Citizens Affected by Major Traffic Accident in the U.S.

Ping An Rapidly Launches Overseas Emergency Assistance to Support Chinese Citizens Affected by Major Traffic Accident in the U.S.

HONG KONG and SHANGHAI , May 3, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group", HKEX: 2318; SSE: 601318) has established the "502 Overseas Emergency Assistance Task Force" to coordinate emergency responses and assistance for Chinese citizens affected by the May 1 traffic accident near Yellowstone National Park in the US.

Prnewswire | 2 months ago
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform today announced that Company management is scheduled to present at the Citizens (JMP) Life Sciences Conference in New York City on Thursday, May 8 at 11:30 AM EDT.

Globenewswire | 2 months ago
Nuvation Bio to Present at The Citizens Life Sciences Conference

Nuvation Bio to Present at The Citizens Life Sciences Conference

NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today announced that Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in a fireside chat at The Citizens Life Sciences Conference on Thursday, May 8, 2025, at 10:00 a.m. ET in New York, NY. A live webcast of the presentation will be available on the Nuvation Bio website at Click Here An ar.

Businesswire | 2 months ago
Prelude Therapeutics to Participate in Citizens Life Sciences Conference

Prelude Therapeutics to Participate in Citizens Life Sciences Conference

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference taking place in New York on May 7, 2025.

Globenewswire | 2 months ago
Gain Therapeutics to Participate at The Citizens Life Sciences Conference

Gain Therapeutics to Participate at The Citizens Life Sciences Conference

BETHESDA, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that Gene Mack, President and CEO of Gain, will present and participate in one-on-one meetings at The Citizens Life Sciences Conference, being held May 7th-8th in New York City, NY.

Globenewswire | 2 months ago
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

ALPHARETTA, Ga., May 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that management will participate in a fireside chat at the Citizens Life Sciences Conference on Wednesday, May 7, 2025, at 1:00 p.m. ET.

Globenewswire | 2 months ago
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

FOSTER CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that members of senior management will be participating in a fireside chat at The Citizens Life Sciences Conference on Wednesday, May 7, 2025 at 2:30 p.m. ET.

Globenewswire | 2 months ago
Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025

Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025

AUSTIN, Texas , April 30, 2025 /PRNewswire/ -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that Brian Windsor, Ph.D., President and Chief Executive Officer, will present at The Citizens Life Sciences Conference 2025 on Thursday, May 8, 2025 at 12:00 p.m.

Prnewswire | 2 months ago
Senti Bio to Present at the Citizens JMP Life Sciences Conference

Senti Bio to Present at the Citizens JMP Life Sciences Conference

Live video webcast presentation on Thursday, May 8 th at 1:00 PM ET Presentation will highlight the recently announced positive preliminary clinical results of lead program, SENTI-202, in the treatment of patients with Relapsed/Refractory AML SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced Timothy Lu, MD, PhD, Co-Founder and CEO of Senti Biosciences will present on Thursday, May 8, 2025 at 1:00 PM ET at the Citizens JMP Life Sciences Conference being held in New York, NY.

Globenewswire | 2 months ago
Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will participate in The Citizens Life Sciences Conference. Details are as follows: Event: The Citizens Life Sciences Conference Date: Wednesday, May 7, 2025 Time: 11:00 AM ET Format: Presentation Webcast: Click Here A replay of the presentation will be available in the Investors section on the Company's website at www.cidara.com.

Globenewswire | 2 months ago
Loading...
Load More